Awarded
Bleeding Disorders including Haemophilia B
£250,000,000
NHS EnglandPfizer Ltd
goods
Contract Details
- Tender Value
- £250,000,000
- Stage
- Awarded
- Published
- Awarded
Timeline
Awarded
Start
Disclosed
End
Description
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months
Related Contracts
From This Buyer
- Clinical Smart Forms
£75,000 ·
- SNOMED CT Refset Creation 2026/27
£104,238 ·
- National Digital Structured Education Content and Platform-(Diabetes) Adults
£3,500,000 ·
- NHS T2DR (previously LCD) Wave 2 Lot 2 BOB
£246,551 ·
From This Supplier
In This Category
Ref: b8e3e14d-0764-46e5-9863-3ae0473aa2e0-556027 · Sourced from Contracts Finder
View source notice